Differences in virulence and immune response induced in a murine model by isolates of Mycobacterium ulcerans from different geographic areas

Clinical and Experimental Immunology

Volumn 157, Issue 2, 2009, Pages 271-281

  Hurtado Ortiz, R ^a   Aguilar Leon, D ^b   Orozco Estevez, H ^b   Martin, A ^c   Luna Herrera, J ^a   Flores Romo, L ^d   Portaels, F ^c   Hernandez Pando, R ^b  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d Center of Research and Advanced Studies   (Mexico)

Author keywords

Animal model; Buruli ulcer; Cytokines; Immunopathology; Mycobacterium ulcerans

Indexed keywords

BETA DEFENSIN 3; BETA DEFENSIN 4; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; MACROLIDE; MYCOLACTONE; POLYPEPTIDE ANTIBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BAGG ALBINO MOUSE; BURULI ULCER; CYTOTOXICITY; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENCE; INFLAMMATION; MOUSE; MYCOBACTERIUM ULCERANS; NONHUMAN; PRIORITY JOURNAL; SKIN NECROSIS; SKIN ULCER; TH1 CELL;

ANIMALS; AUSTRALIA; BENIN; BETA-DEFENSINS; BURULI ULCER; COLONY-FORMING UNITS ASSAY; CONGO; COTE D'IVOIRE; CYTOKINES; GENE EXPRESSION; GHANA; JAPAN; MALAYSIA; MALE; MEXICO; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM ULCERANS; PAPUA NEW GUINEA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; TRINIDAD AND TOBAGO; VIRULENCE;

EID: 67650697970     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03941.x     Document Type: Article

References (29)

1. van der Werf TS, van der Graaf WT, Tappero JW, Asiedu K. Mycobacterium ulcerans infection. Lancet 1991 354 : 1013 8.
2. Asiedu K, Sherpbier R, Raviglione MC. Buruli ulcer Mycobacterium ulcerans infection. WHO Global Buruli Ulcer Initiative Report. Geneva : World Health Organization, 2000.
3. Guarner J, Bartlett J, Whitney EA et al. Histopathologic features of Mycobacterium ulcerans infection. Emerg Infect Dis 2003 9 : 651 6.
4. Roberts B, Hirst R. Immunomagnetic separation and PCR for detection of Mycobacterium ulcerans. J Clin Microbiol 1997 35 : 2709 11.
5. Marsollier L, Robert R, Aubry J et al. Aquatic insects as a vector for Mycobacterium ulcerans. Appl Environ Microbiol 2002 68 : 4623 8.
6. Marsollier L, André JPS, Frigui W et al. Early trafficking events of Mycobacterium ulcerans within Naucoris cimicoides. Cell Microbiol 2007 9 : 347 55.
7. Pahlevan AA, Wright DJM, Andrews C, George KM, Small PLC, Foxwell BM. The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-κB function. J Immunol 1999 163 : 3928 35.
8. George KM, Chatterjee D, Gunawardana G et al. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 1999 283 : 854 7.
9. Stinear TP, Mve-Obiang A, Small PLC et al. Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc Natl Acad Sci USA 2004 101 : 1345 9.
10. Mve-Obiang A, Lee RE, Portaels F, Small PLC. Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence. Infect Immun 2003 71 : 774 83.
11. George KM, Pascopella L, Welty DM, Small PLC. A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect Immun 2000 68 : 877 83.
12. Gooding TM, Johnson PDR, Campbell DE et al. Immune response to infection with Mycobacterium ulcerans. Infect Immun 2001 69 : 1704 7.
13. Coutanceau E, Marsollier L, Brosch R et al. Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin. Cell Microbiol 2005 7 : 1187 96.
14. Prévot G, Bourreau E, Pascalis H et al. Differential production of systemic and intralesional gamma interferon and interleukin-10 in nodular and ulcerative forms of Buruli ulcer. Infect Immun 2004 72 : 958 65.
15. Kiszewski AE, Becerril E, Aguilar LD et al. The local immune response in ulcerative lesions of Buruli ulcer disease. Clin Exp Immunol 2006 143 : 445 51.
16. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003 3 : 710 20.
17. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000 1 : 141 50.
18. Oliveira MS, Fraga AG, Torrado E et al. Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice. Infect Immun 2005 73 : 6299 310.
19. Daniel AK, Lee RE, Portaels F, Small PLC. A analysis of Mycobacterium species for the presence of a macrolide toxin, mycolactone. Infect Immun 2004 72 : 123 32.
20. van der Werf TS, Stinear T, Stienstra Y, van der Graaf WT, Small PL. Mycolactones and Mycobacterium ulcerans disease. Lancet 2003 362 : 1062 64.
21. Gooding MT, Johnson PD, Smith M, Kemp AS, Robins-Browne RM. Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts. Infect Immun 2002 70 : 5562 7.
22. Lee CG, Homer RJ, Zhu Z et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta. J Exp Med 2001 194 : 809 21.
23. Dlugovitzky D, Bay ML, Rateni L et al. In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement. Scand J Immunol 1999 49 : 210 7.
24. Mendez-Samperio P, Hernandez-Garay M, Garcia-Martinez E. Induction of apoptosis in bacillus Calmette-Guerin-activated T cells by transforming growth factor-beta. Cell Immunol 2002 202 : 103 12.
25. Hirsch CS, Johnson JL, Okwera A et al. Mechanisms of apoptosis of T-cells in human tuberculosis. J Clin Immunol 2005 25 : 353 64.
26. Bellkaide Y, Rouse B. Nature regulatory T cells in infectious disease. Nat Immunol 2005 6 : 353 60.
27. Rivas-Santiago B, Schwander SK, Sarabia C et al. Human β-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells. Infect Immun 2005 73 : 4505 11.
28. Durr M, Peschel A. Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect Immun 2002 70 : 6515 7.
29. Rivas-Santiago B, Sada E, Tsutsumi V, Aguilar-Leon D, Contreras JL, Hernandez-Pando R. Beta-defensin gene expression during the course of experimental tuberculosis infection. J Infect Dis 2006 194 : 697 701. (Pubitemid 44297857)